table of content
1 Study Coverage
1.1 Cancer Biological Therapy Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Cancer Biological Therapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cancer Biological Therapy Market Size for the Year 2017-2028
1.2.2 Global Cancer Biological Therapy Market Size for the Year 2017-2028
1.3 Cancer Biological Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Cancer Biological Therapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Cancer Biological Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Cancer Biological Therapy Market Dynamics
1.4.1 Cancer Biological Therapy Industry Trends
1.4.2 Cancer Biological Therapy Market Drivers
1.4.3 Cancer Biological Therapy Market Challenges
1.4.4 Cancer Biological Therapy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Cancer Biological Therapy by Type
2.1 Cancer Biological Therapy Market Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Vaccines
2.1.3 Cancer Growth Blockers
2.1.4 Blood Cell Growth Factors
2.2 Global Cancer Biological Therapy Market Size by Type (2017, 2022 & 2028)
2.3 Global Cancer Biological Therapy Market Size by Type (2017-2028)
2.4 United States Cancer Biological Therapy Market Size by Type (2017, 2022 & 2028)
2.5 United States Cancer Biological Therapy Market Size by Type (2017-2028)
3 Cancer Biological Therapy by Application
3.1 Cancer Biological Therapy Market Segment by Application
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Research & Academic Laboratories
3.1.4 Pharmaceutical & Biotechnology Companies
3.2 Global Cancer Biological Therapy Market Size by Application (2017, 2022 & 2028)
3.3 Global Cancer Biological Therapy Market Size by Application (2017-2028)
3.4 United States Cancer Biological Therapy Market Size by Application (2017, 2022 & 2028)
3.5 United States Cancer Biological Therapy Market Size by Application (2017-2028)
4 Global Cancer Biological Therapy Competitor Landscape by Company
4.1 Global Cancer Biological Therapy Market Size by Company
4.1.1 Top Global Cancer Biological Therapy Companies Ranked by Revenue (2021)
4.1.2 Global Cancer Biological Therapy Revenue by Player (2017-2022)
4.2 Global Cancer Biological Therapy Concentration Ratio (CR)
4.2.1 Cancer Biological Therapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer Biological Therapy in 2021
4.2.3 Global Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cancer Biological Therapy Headquarters, Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Cancer Biological Therapy Headquarters and Area Served
4.3.2 Global Cancer Biological Therapy Companies Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Cancer Biological Therapy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Cancer Biological Therapy Market Size by Company
4.5.1 Top Cancer Biological Therapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cancer Biological Therapy Revenue by Players (2020, 2021 & 2022)
5 Global Cancer Biological Therapy Market Size by Region
5.1 Global Cancer Biological Therapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cancer Biological Therapy Market Size by Region (2017-2028)
5.2.1 Global Cancer Biological Therapy Market Size by Region: 2017-2022
5.2.2 Global Cancer Biological Therapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.1.2 North America Cancer Biological Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cancer Biological Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.3.2 Europe Cancer Biological Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.4.2 Latin America Cancer Biological Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cancer Biological Therapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cancer Biological Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 ELI Lilly
7.1.1 ELI Lilly Company Details
7.1.2 ELI Lilly Business Overview
7.1.3 ELI Lilly Cancer Biological Therapy Introduction
7.1.4 ELI Lilly Revenue in Cancer Biological Therapy Business (2017-2022)
7.1.5 ELI Lilly Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Cancer Biological Therapy Introduction
7.2.4 Sanofi Revenue in Cancer Biological Therapy Business (2017-2022)
7.2.5 Sanofi Recent Development
7.3 Merck
7.3.1 Merck Company Details
7.3.2 Merck Business Overview
7.3.3 Merck Cancer Biological Therapy Introduction
7.3.4 Merck Revenue in Cancer Biological Therapy Business (2017-2022)
7.3.5 Merck Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Cancer Biological Therapy Introduction
7.4.4 Bayer Revenue in Cancer Biological Therapy Business (2017-2022)
7.4.5 Bayer Recent Development
7.5 Roche
7.5.1 Roche Company Details
7.5.2 Roche Business Overview
7.5.3 Roche Cancer Biological Therapy Introduction
7.5.4 Roche Revenue in Cancer Biological Therapy Business (2017-2022)
7.5.5 Roche Recent Development
7.6 Novartis International
7.6.1 Novartis International Company Details
7.6.2 Novartis International Business Overview
7.6.3 Novartis International Cancer Biological Therapy Introduction
7.6.4 Novartis International Revenue in Cancer Biological Therapy Business (2017-2022)
7.6.5 Novartis International Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Details
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Cancer Biological Therapy Introduction
7.7.4 Pfizer Revenue in Cancer Biological Therapy Business (2017-2022)
7.7.5 Pfizer Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Cancer Biological Therapy Introduction
7.8.4 Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2017-2022)
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Seattle Genetics
7.9.1 Seattle Genetics Company Details
7.9.2 Seattle Genetics Business Overview
7.9.3 Seattle Genetics Cancer Biological Therapy Introduction
7.9.4 Seattle Genetics Revenue in Cancer Biological Therapy Business (2017-2022)
7.9.5 Seattle Genetics Recent Development
7.10 Amgen
7.10.1 Amgen Company Details
7.10.2 Amgen Business Overview
7.10.3 Amgen Cancer Biological Therapy Introduction
7.10.4 Amgen Revenue in Cancer Biological Therapy Business (2017-2022)
7.10.5 Amgen Recent Development
7.11 Takeda Pharmaceuticals
7.11.1 Takeda Pharmaceuticals Company Details
7.11.2 Takeda Pharmaceuticals Business Overview
7.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Introduction
7.11.4 Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022)
7.11.5 Takeda Pharmaceuticals Recent Development
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Company Details
7.12.2 GlaxoSmithKline Business Overview
7.12.3 GlaxoSmithKline Cancer Biological Therapy Introduction
7.12.4 GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2017-2022)
7.12.5 GlaxoSmithKline Recent Development
7.13 Spectrum Pharmaceuticals
7.13.1 Spectrum Pharmaceuticals Company Details
7.13.2 Spectrum Pharmaceuticals Business Overview
7.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Introduction
7.13.4 Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022)
7.13.5 Spectrum Pharmaceuticals Recent Development
7.14 Celgene Corporation
7.14.1 Celgene Corporation Company Details
7.14.2 Celgene Corporation Business Overview
7.14.3 Celgene Corporation Cancer Biological Therapy Introduction
7.14.4 Celgene Corporation Revenue in Cancer Biological Therapy Business (2017-2022)
7.14.5 Celgene Corporation Recent Development
7.15 AstraZeneca, Plc.
7.15.1 AstraZeneca, Plc. Company Details
7.15.2 AstraZeneca, Plc. Business Overview
7.15.3 AstraZeneca, Plc. Cancer Biological Therapy Introduction
7.15.4 AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2017-2022)
7.15.5 AstraZeneca, Plc. Recent Development
7.16 Otsuka
7.16.1 Otsuka Company Details
7.16.2 Otsuka Business Overview
7.16.3 Otsuka Cancer Biological Therapy Introduction
7.16.4 Otsuka Revenue in Cancer Biological Therapy Business (2017-2022)
7.16.5 Otsuka Recent Development
7.17 Eisai
7.17.1 Eisai Company Details
7.17.2 Eisai Business Overview
7.17.3 Eisai Cancer Biological Therapy Introduction
7.17.4 Eisai Revenue in Cancer Biological Therapy Business (2017-2022)
7.17.5 Eisai Recent Development
7.18 Abbvie
7.18.1 Abbvie Company Details
7.18.2 Abbvie Business Overview
7.18.3 Abbvie Cancer Biological Therapy Introduction
7.18.4 Abbvie Revenue in Cancer Biological Therapy Business (2017-2022)
7.18.5 Abbvie Recent Development
7.19 Incyte
7.19.1 Incyte Company Details
7.19.2 Incyte Business Overview
7.19.3 Incyte Cancer Biological Therapy Introduction
7.19.4 Incyte Revenue in Cancer Biological Therapy Business (2017-2022)
7.19.5 Incyte Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
